Aurobindo Pharma gets 7 observations from USFDA for Telangana Unit

09 Oct 2019 Evaluate

Aurobindo Pharma has received 7 observations from the United States Food and Drug Administration (USFDA) for its unit-7 in Telangana. The USFDA had conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7 manufacturing facility from September 19 to 27. The company is confident of addressing these issues within the stipulated timeline.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1188.50 -28.95 (-2.38%)
08-Dec-2025 12:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.75
Dr. Reddys Lab 1269.90
Cipla 1508.15
Zydus Lifesciences 926.00
Lupin 2070.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×